Trends in utilization of stored cryopreserved autologous peripheral hematopoietic cells intended for a second (or beyond) autologous hematopoietic cell transplantation in patients with multiple myeloma: a single center experience

Due to the advent of effective novel therapies for multiple myeloma (MM), the use of cryopreserved autologous peripheral blood hematopoietic cells (APBHC) for a salvage autologous transplant (auto-HCT) is in decline. We evaluated utilization trends and costs associated with cryopreserved APBHC in pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Yassine, Farah, Kharfan-Dabaja, Mohamed A., Tsalantsanis, Athanasios, Roy, Vivek, Zubair, Abba C., Murthy, Hemant S., Ayala, Ernesto, Iqbal, Madiha, Sher, Taimur, Ailawadhi, Sikander, Parrondo, Ricardo D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555832/
https://www.ncbi.nlm.nih.gov/pubmed/37479753
http://dx.doi.org/10.1038/s41409-023-02035-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555832/
https://www.ncbi.nlm.nih.gov/pubmed/37479753
http://dx.doi.org/10.1038/s41409-023-02035-y

Ejemplares similares